government
Evidence pageSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception
US Food and Drug Administration (CBER)
accessed Sep 18, 2026Updated Sep 19, 2026
Original source
fda.gov
Verification
| Verification | Not yet verified |
| Evidence level | — |
| Source | government |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (12)
FactAutologous Fat: FDA guidance on exception scope = CBER final guidance, 'Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers', issued November 2017FactBreast Fat Grafting: Relevant FDA guidance = Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the ExceptionAnswerCan your body reject your own fat after a fat transfer?AnswerHow much transferred autologous fat survives?AnswerWhich body area is best for harvesting fat for grafting?AnswerIs autologous fat the same as SVF or stem cells?AnswerWhat are the risks of autologous fat transfer?Answer일반 지방이식과 SVF 지방이식의 차이는 무엇인가요?Answer일반 지방이식과 줄기세포 지방이식의 차이는 시술 과정 중 어느 단계에서 생기나요?Answer일반 지방이식과 줄기세포 지방이식 차이, 줄기세포 치료와 같은 뜻인가요?AnswerSVF 얼굴성형, 어떤 원리의 시술이며 효과 근거는 어느 정도인가요?ArticleAutologous Fat: Definition, Composition, Biology, Uses and Safety